SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-033241
Filing Date
2023-09-21
Accepted
2023-09-20 17:40:59
Documents
14
Period of Report
2023-09-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 110309
2 ex99-1.htm EX-99.1 17997
  Complete submission text file 0001493152-23-033241.txt   367748

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT murf-20230920.xsd EX-101.SCH 4204
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT murf-20230920_def.xml EX-101.DEF 27332
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT murf-20230920_lab.xml EX-101.LAB 37930
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT murf-20230920_pre.xml EX-101.PRE 25952
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6955
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
Murphy Canyon Acquisition Corp. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 231267302
SIC: 2834 Pharmaceutical Preparations